Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhalable formulation of a solution containing vilanterol trifenatate and umeclidinium bromide

Inhalable formulation of a solution containing vilanterol trifenatate and umeclidinium bromide

US Patent 11642333 · Granted May 9, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Hydrogen bond induced high stability porous covalent organic gel material and pr2024
Ultrafiltration/nanofiltration membrane with tunable pore size2024
Inhalation atomizer comprising a blocking function and a counter2022
Formulation of tocilizumab and method for treating COVID-19 by inhalation2022
Pharmaceutical formulation containing umeclidinium bromide and vilanterol trifen2022
Liposome formulation of fluticasone furoate and method of preparation2022
Method for preparing gold nanorods having high catalytic activity by using femto2021
Liposome formulation of vilanterol trifenatate2021
Crystal form of dezocine and preparation method therefor2021
Preparation method for 2,3-pentanedione2019
Synthesis method of 3,4-hexanedione2018
Social media with multi-level relationships2018